Curaleaf (OTCMKTS:CURLF) Sees Strong Trading Volume – Here’s What Happened

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF) saw strong trading volume on Friday . 807,439 shares were traded during mid-day trading, a decline of 6% from the previous session’s volume of 863,313 shares.The stock last traded at $3.36 and had previously closed at $3.1940.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. ATB Capital raised Curaleaf to an “outperform” rating in a research report on Tuesday, December 2nd. Canaccord Genuity Group raised Curaleaf to a “strong-buy” rating in a research report on Thursday, October 9th. Finally, Atb Cap Markets upgraded shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 2nd. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Strong Buy”.

Curaleaf Stock Up 0.8%

The stock has a market cap of $2.18 billion, a PE ratio of -10.06 and a beta of 0.77. The business has a 50 day moving average price of $2.76 and a 200 day moving average price of $2.20. The company has a quick ratio of 0.71, a current ratio of 1.47 and a debt-to-equity ratio of 0.96.

Curaleaf (OTCMKTS:CURLF) last announced its quarterly earnings results on Wednesday, November 5th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative return on equity of 15.57% and a negative net margin of 19.50%. Equities research analysts expect that Curaleaf Holdings, Inc. will post -0.25 EPS for the current fiscal year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.